Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $34.6300 (6.78%) ($32.8900 - $35.2000) on Wed. Oct. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.84% (three month average) | RSI | 59 | Latest Price | $34.6300(6.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 4.3% a day on average for past five trading days. | Weekly Trend | IOVA declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(47%) XBI(44%) ARKG(43%) IWO(41%) ARKK(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.92% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-12%) TBT(-6%) UNG(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.92% (StdDev 3.84%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $31.76(9.04%) | 10 Day Moving Average | $31.24(10.85%) | 20 Day Moving Average | $32.21(7.51%) | To recent high | -4.4% | To recent low | 24.8% | Market Cap | $5.071b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |